Subramaniam S S, Breik O, Cadd B, Peart G, Wiesenfeld D, Heggie A, Gibbons S D, Nastri A
Oral and Maxillofacial Surgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Oral and Maxillofacial Surgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Int J Oral Maxillofac Surg. 2018 Jun;47(6):773-782. doi: 10.1016/j.ijom.2018.01.013. Epub 2018 Feb 7.
The aim of this study was to evaluate the long-term survival of craniofacial implants and prostheses and to identify factors associated with failure in a cohort of patients. A 25-year retrospective analysis was conducted at Royal Melbourne Hospital. Data included demographic characteristics, age, site and cause of the deformity, and number and survival of implants. Odds ratios were calculated and event-to-time Kaplan-Meier analyses performed. One hundred and ten patients were included (341 implants); their mean age was 46.2 years. The overall implant survival rate was 79.5% (mean follow-up 10.6 years). Temporal implants had the highest success rate (97.0%), followed by nasal implants (87.5%) and orbital implants (63.3%); differences were statistically significant (P<0.0001 and P=0.033, respectively). Kaplan-Meier analyses to determine long-term implant and prosthesis survival found temporal implants had the highest prosthetic (P<0.0001) and implant survival (P<0.0001). Patients with congenital deformities demonstrated the highest success rate. Radiotherapy was found to increase the risk of implant failure (P=0.02). Craniofacial implant-retained prostheses are a reliable and effective option for the restoration of facial defects, with good long-term success rates. Orbital implants and those placed post oncological surgery have a higher failure rate.
本研究旨在评估颅面植入物和假体的长期存活率,并确定一组患者中与失败相关的因素。在皇家墨尔本医院进行了一项为期25年的回顾性分析。数据包括人口统计学特征、年龄、畸形部位和原因,以及植入物的数量和存活率。计算比值比并进行事件到时间的Kaplan-Meier分析。纳入了110名患者(341个植入物);他们的平均年龄为46.2岁。总体植入物存活率为79.5%(平均随访10.6年)。颞部植入物成功率最高(97.0%),其次是鼻部植入物(87.5%)和眼眶植入物(63.3%);差异具有统计学意义(分别为P<0.0001和P=0.033)。用于确定长期植入物和假体存活率的Kaplan-Meier分析发现,颞部植入物的假体存活率(P<0.0001)和植入物存活率(P<0.0001)最高。先天性畸形患者的成功率最高。发现放疗会增加植入物失败的风险(P=0.02)。颅面植入物保留的假体是修复面部缺损的可靠且有效的选择,长期成功率良好。眼眶植入物以及肿瘤手术后植入的植入物失败率较高。